Literature DB >> 30556871

Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.

M Liu1, X Gao, C-L Liu.   

Abstract

OBJECTIVE: Growing evidence indicated that long noncoding RNAs (lncRNAs) played important roles in tumor initiation and progression. In this study, we aimed to investigate the expression pattern, clinical significance, and biological function of lncRNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) in oral squamous cell carcinoma (OSCC). PATIENTS AND METHODS: We evaluated the expression levels of FTH1P3 in OSCC tissues, adjacent normal tissues and cells with quantitative Real-time polymerase chain reaction. Kaplan-Meier curves and multivariate Cox proportional models were used to study the impact on clinical outcome. Effect of FTH1P3 on the proliferation migration and invasion of OSCC cells was estimated by MTT, wound-healing, and transwell assays. Western blot was performed to investigate the effects of FTH1P3 on expression of PI3K/Akt/GSK3β-related molecules, and Wnt/β-catenin signaling components.
RESULTS: The expression level of FTH1P3 was significantly upregulated in OSCC tissues and cell lines. Higher expression of FTH1P3 in OSCC tissue was associated with T classification, N classification and TNM stage. Furthermore, Kaplan-Meier survival analysis showed that prognosis of patients with low FTH1P3 expression was much better than that of those with high expression. Cox regression analysis showed that FTH1P3 expression was an independent prognosis-predicting factor for OSCC patients. Loss-function assay showed that knockdown of FTH1P3 significantly suppressed the proliferation, migration and invasion of OSCC cells. Mechanistically, we found that knockdown of FTH1P3 significantly reduced the activation of PI3K/Akt/GSK3β/Wnt/β-catenin signaling.
CONCLUSIONS: We demonstrated that FTH1P3 acted as a tumor promoter by regulating PI3K/Akt/GSK3β/Wnt/β-catenin signaling and could represent a novel prognostic marker in OSCC patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30556871     DOI: 10.26355/eurrev_201812_16528

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

1.  Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.

Authors:  Meng Wang; Zhigang Feng; Xiaoxi Li; Shulan Sun; Li Lu
Journal:  Mol Cell Biochem       Date:  2021-03-01       Impact factor: 3.396

2.  Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma.

Authors:  Yongfa Zeng; Ying Kong; Lan Liao; Hongshui Zhu
Journal:  Dis Markers       Date:  2022-04-22       Impact factor: 3.464

3.  A tannin compound from Sanguisorba officinalis blocks Wnt/β-catenin signaling pathway and induces apoptosis of colorectal cancer cells.

Authors:  Wa Li; Chun-Juan Yang; Li-Qian Wang; Juan Wu; Cong Dai; Yue-Mei Yuan; George Q Li; Mei-Cun Yao
Journal:  Chin Med       Date:  2019-05-31       Impact factor: 5.455

Review 4.  Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Authors:  Choudhary Harsha; Kishore Banik; Hui Li Ang; Sosmitha Girisa; Rajesh Vikkurthi; Dey Parama; Varsha Rana; Bano Shabnam; Elina Khatoon; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

Review 5.  FTH1 Pseudogenes in Cancer and Cell Metabolism.

Authors:  Maddalena Di Sanzo; Barbara Quaresima; Flavia Biamonte; Camillo Palmieri; Maria Concetta Faniello
Journal:  Cells       Date:  2020-11-28       Impact factor: 6.600

6.  Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.

Authors:  Xiujuan Zhang; Xiaole Song; Yuting Lai; Bijun Zhu; Jiqin Luo; Hongmeng Yu; Yiqun Yu
Journal:  BMC Cancer       Date:  2021-04-30       Impact factor: 4.430

Review 7.  The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma.

Authors:  Man Jiang; Fang Liu; An-Gang Yang; Wei Wang; Rui Zhang
Journal:  Mol Ther Oncolytics       Date:  2021-12-06       Impact factor: 7.200

8.  Identification of a robust non-coding RNA signature in diagnosing autism spectrum disorder by cross-validation of microarray data from peripheral blood samples.

Authors:  Wei Cheng; Shanhu Zhou; Jinxia Zhou; Xijia Wang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

9.  Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.

Authors:  Qian Zhu; Ai-Lin Zhong; Hao Hu; Jing-Jing Zhao; De-Sheng Weng; Yan Tang; Qiu-Zhong Pan; Zi-Qi Zhou; Meng-Jia Song; Jie-Ying Yang; Jun-Yi He; Yuan Liu; Min Li; Wan-Ming Hu; Chao-Pin Yang; Tong Xiang; Ming-Yuan Chen; Gang Ma; Ling Guo; Jian-Chuan Xia
Journal:  J Hematol Oncol       Date:  2020-01-03       Impact factor: 17.388

Review 10.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.